CAS 1800066-24-3

HPB

CAS : 1800066-24-3

HPB is a drug that is used to treat metabolic disorders in geriatric patients. The body excretes HPB through urine and feces, where it can be found in wastewater treatment plants. HPB is hydrolyzed by a number of enzymes, including esterases, glutathione reductase, and cytochrome p450. The reaction mechanism of HPB involves hydrogen bonding with the substrate film and the formation of a molecule that reacts with the enzyme. The mechanism of action for HPB includes the inhibition of bacterial translocation, which may be due to its ability to inhibit inflammatory bowel disease or primary sclerosing cholangitis.

Formule : C₁₈H₂₀N₂O₄

Degré de pureté : Min. 95%

Masse moléculaire : 328.4 g/mol

Ref: 3D-AXC06624

HPB

CAS : 1800066-24-3

HPB is a selective HDAC6 deacetylase inhibitor

Formule : C₁₈H₂₀N₂O₄

Couleur et forme : Solid

Masse moléculaire : 328.36

Ref: TM-T27553